Profile data is unavailable for this security.
About the company
Halberd Corporation is a technology holding company. The Company is focused on developing solutions for healthcare and medical applications. Its portfolio includes approaches to disease treatment, diagnostic technologies, and artificial intelligence (AI)-powered healthcare platforms. It has acquired licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid-related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its subsidiary, NeuroSense AI Corp., is a behavioral intelligence platform in development combining AI with multi-modal sensor technology that integrates ultrasonic vocalization analysis, micro-movement tracking, and social behavior monitoring through Claude AI-powered interpretation to provide unprecedented insights into brain health and recovery patterns. Its subsidiaries also include Alaric Corporation and Extendalife, Inc.
- Revenue in USD (TTM)281.24k
- Net income in USD25.34k
- Incorporated2020
- Employees3.00
- LocationHalberd CorpP.O. Box 25JACKSON CENTER 16133United StatesUSA
- Websitehttps://halberdcorporation.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepion Pharmaceuticals Inc | 0.00 | -9.17m | 662.36k | 22.00 | -- | 0.4065 | -- | -- | -13.39 | -13.39 | 0.00 | 0.2861 | 0.00 | -- | -- | -- | -245.96 | -65.13 | -417.51 | -73.82 | -- | -- | -- | -- | -- | -5.25 | 0.0606 | -- | -- | -- | 73.04 | -- | -- | -- |
| Protagenic Therapeutics Inc | -100.00bn | -100.00bn | 769.40k | 1.00 | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2945 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| CeCors Inc | -100.00bn | -100.00bn | 826.55k | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| PMGC Holdings Inc | 285.95k | -4.48m | 854.65k | 2.00 | -- | 0.0368 | -- | 2.99 | -57.57 | -129.01 | 3.93 | 45.64 | 0.0219 | 0.373 | 1.98 | 142,975.00 | -34.29 | -- | -48.32 | -- | 27.29 | -- | -1,567.42 | -- | 1.77 | -32.16 | 0.2734 | -- | -- | -- | -142.45 | -- | -- | -- |
| Lipella Pharmaceuticals Inc | 389.79k | -5.33m | 855.32k | 5.00 | -- | 0.575 | -- | 2.19 | -2.41 | -2.41 | 0.1286 | 0.3219 | 0.1729 | -- | 25.08 | 77,958.00 | -236.36 | -101.93 | -336.65 | -125.09 | -- | -- | -1,367.34 | -592.18 | -- | -- | 0.00 | -- | 19.29 | -5.04 | -8.60 | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -49.19m | 949.62k | 8.00 | -- | -- | -- | -- | -175.56 | -175.56 | 0.00 | -3.04 | 0.00 | -- | -- | 0.00 | -282.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.12 | -- | -- | -- |
| Emmaus Life Sciences Inc | 11.89m | -7.29m | 985.89k | 34.00 | -- | -- | -- | 0.0829 | -0.1141 | -0.1141 | 0.1862 | -0.9315 | 0.4945 | 0.6596 | 3.13 | 349,794.10 | -30.31 | -14.68 | -- | -211.99 | 92.17 | 90.14 | -61.29 | -32.65 | 0.0557 | -0.1912 | -- | -- | -43.73 | -6.05 | -72.86 | -- | -27.52 | -- |
| Halberd Corp | 281.24k | 25.34k | 1.13m | 3.00 | 0.6897 | -- | 44.61 | 4.02 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
| Aditxt Inc | 5.95k | -42.24m | 1.25m | 26.00 | -- | -- | -- | 209.84 | -13,234.74 | -13,234.74 | 0.3444 | -151.86 | 0.0003 | 1.54 | 0.0304 | 228.85 | -207.03 | -148.78 | -- | -279.11 | -1,134.96 | -- | -724,419.70 | -8,283.15 | 0.02 | -12.48 | -- | -- | -79.23 | -- | -23.40 | -- | -- | -- |
| International Stem Cell Corp | 9.39m | -149.00k | 1.32m | 32.00 | -- | -- | 8.20 | 0.1406 | -0.0187 | -0.0187 | 1.17 | 0.0655 | 1.80 | 2.66 | 11.08 | 293,468.80 | -1.13 | -16.11 | -10.84 | -52.88 | 57.86 | 59.53 | -0.6283 | -10.91 | 0.4604 | 0.6258 | 0.8632 | -- | 16.64 | -0.8308 | -59.54 | -- | -19.12 | -- |
| Exousia Pro Inc | 0.00 | -854.02k | 1.43m | 0.00 | -- | -- | -- | -- | -0.0642 | -0.0642 | 0.00 | -0.0318 | 0.00 | -- | -- | -- | -1,313,877.00 | -- | -- | -- | -- | -- | -- | -- | -- | -1,816.06 | -- | -- | -- | -- | -248.31 | -- | -- | -- |
| Pharmagreen Biotech Inc | 3.01k | -226.26k | 1.45m | 0.00 | -- | -- | 2.63 | 482.85 | -0.0003 | -0.0003 | 0.00 | -0.0035 | 0.0286 | 0.2026 | 0.0669 | -- | -214.92 | -709.50 | -- | -- | 44.85 | -- | -7,518.27 | -147,637.60 | 0.0375 | -- | -- | -- | 13.67 | -- | -76.59 | -- | -- | -- |
| GlucoTrack Inc | 0.00 | -25.85m | 1.59m | 11.00 | -- | 0.5721 | -- | -- | -1,225.32 | -1,225.32 | 0.00 | 3.06 | 0.00 | -- | -- | 0.00 | -567.22 | -147.48 | -- | -192.87 | -- | -- | -- | -- | -- | -3.51 | 0.5422 | -- | -- | -- | -218.40 | -- | 34.73 | -- |
| Holder | Shares | % Held |
|---|---|---|
| ORG Wealth Partners LLCas of 31 Dec 2025 | 0.00 | 0.00% |
